Abich Financial Wealth Management’s Arcus Biosciences RCUS Stock Holding History

Abich Financial Wealth Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$69.3K	Buy	+5,096	New	+$53K	0.02%	269

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Abich Financial Wealth Management's RCUS Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Arcus Biosciences (RCUS) in Q3 2025: 5,096 shares worth $69.3K. The stake represents 0.02% of the portfolio and ranks #269 among its holdings.

190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

Abich Financial Wealth Management held 5,096 shares of Arcus Biosciences worth $69.3K as of Q3 2025.
Arcus Biosciences was a new Abich Financial Wealth Management position in Q3 2025.
Arcus Biosciences made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2025, its #269 holding.
190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.